|
2020-12-11 |
2020-12-09 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
2,793
-49.7%
79.69
USD 222,574
|
2,793
-49.7%
|
79.69
|
USD 222,574
|
|
|
2020-11-17 |
2020-11-16 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
7,603
-57.5%
86.57
USD 658,192
|
7,603
-57.5%
|
86.57
|
USD 658,192
|
|
|
2020-11-17 |
2020-11-13 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
13,282
-70.3%
83.82
USD 1,113,318
|
13,282
-70.3%
|
83.82
|
USD 1,113,318
|
|
|
2020-11-12 |
2020-11-10 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
6,000
-51.6%
81.57
USD 489,420
|
6,000
-51.6%
|
81.57
|
USD 489,420
|
|
|
2020-11-06 |
2020-11-05 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
3,589
-39.0%
79.87
USD 286,653
|
3,589
-39.0%
|
79.87
|
USD 286,653
|
|
|
2020-11-06 |
2020-11-04 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
3,434
-37.9%
79.89
USD 274,351
|
3,434
-37.9%
|
79.89
|
USD 274,351
|
|
|
2020-11-06 |
2020-11-04 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
139
-0.6%
80.00
USD 11,120
|
139
-0.6%
|
80.00
|
USD 11,120
|
|
|
2020-11-06 |
2020-11-04 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
2,481
-9.7%
80.00
USD 198,481
|
2,481
-9.7%
|
80.00
|
USD 198,481
|
|
|
2020-10-20 |
2020-10-16 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
183
-3.2%
79.87
USD 14,616
|
183
-3.2%
|
79.87
|
USD 14,616
|
|
|
2020-10-07 |
2020-10-07 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,500
-6.1%
78.50
USD 117,753
|
1,500
-6.1%
|
78.50
|
USD 117,753
|
|
|
2020-10-07 |
2020-10-06 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
4,778
-17.2%
78.50
USD 375,094
|
4,778
-17.2%
|
78.50
|
USD 375,094
|
|
|
2020-10-07 |
2020-10-05 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
14,637
-38.9%
78.51
USD 1,149,110
|
14,637
-38.9%
|
78.51
|
USD 1,149,110
|
|
|
2020-06-10 |
2020-06-08 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,415
-5.8%
78.50
USD 111,078
|
1,415
-5.8%
|
78.50
|
USD 111,078
|
|
|
2020-05-19 |
2020-05-15 |
B
Purchase
|
MURRAY JAMES E
President and COO
Officer
|
4,500
+inf%
67.63
USD 304,317
|
4,500
+inf%
|
67.63
|
USD 304,317
|
|
|
2020-01-03 |
2020-01-02 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
200
-1.0%
78.53
USD 15,706
|
200
-1.0%
|
78.53
|
USD 15,706
|
|
|
2019-12-31 |
2019-12-30 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
104
-0.5%
78.50
USD 8,164
|
104
-0.5%
|
78.50
|
USD 8,164
|
|
|
2019-12-30 |
2019-12-27 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
606
-2.9%
78.54
USD 47,597
|
606
-2.9%
|
78.54
|
USD 47,597
|
|
|
2019-12-27 |
2019-12-26 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,923
-8.7%
78.52
USD 150,987
|
1,923
-8.7%
|
78.52
|
USD 150,987
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
6,114
-23.3%
78.54
USD 480,166
|
6,114
-23.3%
|
78.54
|
USD 480,166
|
|
|
2019-12-17 |
2019-12-16 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
5,735
-22.1%
78.62
USD 450,886
|
5,735
-22.1%
|
78.62
|
USD 450,886
|
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
16,766
-85.7%
78.72
USD 1,319,742
|
16,766
-85.7%
|
78.72
|
USD 1,319,742
|
|
|
2018-07-03 |
2018-07-02 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-30.5%
95.86
USD 1,282,061
|
13,375
-30.5%
|
95.86
|
USD 1,282,061
|
|
|
2018-06-04 |
2018-06-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-30.5%
92.21
USD 1,233,326
|
13,375
-30.5%
|
92.21
|
USD 1,233,326
|
|
|
2018-05-02 |
2018-05-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-23.2%
86.02
USD 1,150,576
|
13,375
-23.2%
|
86.02
|
USD 1,150,576
|
|
|
2018-04-04 |
2018-04-02 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
Officer
|
1,666
-100.0%
106.20
USD 176,929
|
1,666
-100.0%
|
106.20
|
USD 176,929
|
|
|
2018-04-04 |
2018-04-02 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-23.2%
103.52
USD 1,384,583
|
13,375
-23.2%
|
103.52
|
USD 1,384,583
|
|
|
2018-03-06 |
2018-03-05 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
15,428
-100.0%
99.04
USD 1,527,968
|
15,428
-100.0%
|
99.04
|
USD 1,527,968
|
|
|
2018-03-06 |
2018-03-05 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
22,875
-63.0%
99.05
USD 2,265,698
|
22,875
-63.0%
|
99.05
|
USD 2,265,698
|
|
|
2018-03-02 |
2018-03-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-31.2%
101.20
USD 1,353,497
|
13,375
-31.2%
|
101.20
|
USD 1,353,497
|
|
|
2018-02-02 |
2018-02-01 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,375
-31.2%
99.20
USD 1,326,765
|
13,375
-31.2%
|
99.20
|
USD 1,326,765
|
|
|
2018-01-04 |
2018-01-03 |
S
Sale
|
Rubin Jonathan N
Chief Financial Officer
Officer
|
30,086
-53.2%
96.16
USD 2,893,028
|
30,086
-53.2%
|
96.16
|
USD 2,893,028
|
|
|
2018-01-03 |
2018-01-02 |
S
Sale
|
SMITH BARRY M
Chief Executive Officer
Executive Director
|
13,367
-31.2%
95.94
USD 1,282,429
|
13,367
-31.2%
|
95.94
|
USD 1,282,429
|
|
|
2018-01-03 |
2018-01-02 |
S
Sale
|
Rubin Jonathan N
Chief Financial Officer
Officer
|
17,443
-39.7%
96.07
USD 1,675,782
|
17,443
-39.7%
|
96.07
|
USD 1,675,782
|
|
|
2017-12-06 |
2017-12-04 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
2,180
-100.0%
92.00
USD 200,560
|
2,180
-100.0%
|
92.00
|
USD 200,560
|
|
|
2017-12-05 |
2017-12-04 |
S
Sale
|
Lewis Clapper Caskie
Chief Human Resources Officer
|
59,313
-76.3%
93.99
USD 5,574,586
|
59,313
-76.3%
|
93.99
|
USD 5,574,586
|
|
|
2017-12-04 |
2017-12-01 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
8,275
-38.1%
89.08
USD 737,137
|
8,275
-38.1%
|
89.08
|
USD 737,137
|
|
|
2017-11-02 |
2017-11-01 |
PS
Planned sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
9,369
-41.0%
89.20
USD 835,751
|
9,369
-41.0%
|
89.20
|
USD 835,751
|
|
|
2017-11-02 |
2017-11-01 |
PS
Planned sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1,154
-100.0%
92.00
USD 106,168
|
1,154
-100.0%
|
92.00
|
USD 106,168
|
|
|
2017-10-05 |
2017-10-04 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
2,475
-15.5%
88.10
USD 218,048
|
2,475
-15.5%
|
88.10
|
USD 218,048
|
|
|
2017-10-05 |
2017-10-04 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
5,000
-23.9%
88.00
USD 440,000
|
5,000
-23.9%
|
88.00
|
USD 440,000
|
|
|
2017-10-05 |
2017-10-03 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
5,000
-27.1%
88.00
USD 440,000
|
5,000
-27.1%
|
88.00
|
USD 440,000
|
|
|
2017-10-04 |
2017-10-03 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
30,021
-68.3%
87.31
USD 2,621,242
|
30,021
-68.3%
|
87.31
|
USD 2,621,242
|
|
|
2017-10-03 |
2017-10-02 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
19,007
-57.7%
86.22
USD 1,638,689
|
19,007
-57.7%
|
86.22
|
USD 1,638,689
|
|
|
2017-10-03 |
2017-09-29 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
18,511
-57.1%
86.18
USD 1,595,317
|
18,511
-57.1%
|
86.18
|
USD 1,595,317
|
|
|
2017-09-29 |
2017-09-28 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
4,848
-100.0%
85.76
USD 415,782
|
4,848
-100.0%
|
85.76
|
USD 415,782
|
|
|
2017-09-29 |
2017-09-28 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
25,316
-64.5%
85.85
USD 2,173,452
|
25,316
-64.5%
|
85.85
|
USD 2,173,452
|
|
|
2017-09-29 |
2017-09-27 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
1,419
-9.2%
86.06
USD 122,125
|
1,419
-9.2%
|
86.06
|
USD 122,125
|
|
|
2017-09-29 |
2017-09-27 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
|
18,502
-54.7%
85.24
USD 1,577,131
|
18,502
-54.7%
|
85.24
|
USD 1,577,131
|
|
|
2017-09-28 |
2017-09-27 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
35,658
-72.6%
85.17
USD 3,036,928
|
35,658
-72.6%
|
85.17
|
USD 3,036,928
|
|
|
2017-09-28 |
2017-09-27 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
600
-100.0%
86.06
USD 51,635
|
600
-100.0%
|
86.06
|
USD 51,635
|
|
|
2017-09-28 |
2017-09-27 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
18,526
-96.9%
85.31
USD 1,580,373
|
18,526
-96.9%
|
85.31
|
USD 1,580,373
|
|
|
2017-09-18 |
2017-09-15 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
2,402
-15.1%
83.00
USD 199,366
|
2,402
-15.1%
|
83.00
|
USD 199,366
|
|
|
2017-09-18 |
2017-09-15 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
2,961
-100.0%
84.00
USD 248,724
|
2,961
-100.0%
|
84.00
|
USD 248,724
|
|
|
2017-09-18 |
2017-09-14 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
18,063
-57.3%
83.05
USD 1,500,163
|
18,063
-57.3%
|
83.05
|
USD 1,500,163
|
|
|
2017-09-14 |
2017-09-13 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
585
-100.0%
83.00
USD 48,555
|
585
-100.0%
|
83.00
|
USD 48,555
|
|
|
2017-09-14 |
2017-09-13 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
14,096
-51.2%
83.06
USD 1,170,883
|
14,096
-51.2%
|
83.06
|
USD 1,170,883
|
|
|
2017-09-14 |
2017-09-12 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
19
-100.0%
83.00
USD 1,577
|
19
-100.0%
|
83.00
|
USD 1,577
|
|
|
2017-09-12 |
2017-09-11 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
670
-100.0%
83.00
USD 55,610
|
670
-100.0%
|
83.00
|
USD 55,610
|
|
|
2017-09-12 |
2017-09-11 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
2,400
-15.1%
83.00
USD 199,200
|
2,400
-15.1%
|
83.00
|
USD 199,200
|
|
|
2017-09-11 |
2017-09-08 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
6,267
-100.0%
81.53
USD 510,918
|
6,267
-100.0%
|
81.53
|
USD 510,918
|
|
|
2017-09-08 |
2017-09-07 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1,033
-100.0%
81.19
USD 83,870
|
1,033
-100.0%
|
81.19
|
USD 83,870
|
|
|
2017-09-08 |
2017-09-05 |
S
Sale
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1,157
-100.0%
80.96
USD 93,669
|
1,157
-100.0%
|
80.96
|
USD 93,669
|
|
|
2017-07-26 |
2017-07-25 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
4,559
-25.3%
80.68
USD 367,820
|
4,559
-25.3%
|
80.68
|
USD 367,820
|
|
|
2017-07-25 |
2017-07-24 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
32,398
-70.7%
80.12
USD 2,595,582
|
32,398
-70.7%
|
80.12
|
USD 2,595,582
|
|
|
2017-07-25 |
2017-07-21 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
1,176
-8.0%
80.02
USD 94,102
|
1,176
-8.0%
|
80.02
|
USD 94,102
|
|
|
2017-07-21 |
2017-07-20 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
16,073
-54.4%
80.06
USD 1,286,751
|
16,073
-54.4%
|
80.06
|
USD 1,286,751
|
|
|
2017-07-21 |
2017-07-20 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
1,109
-7.4%
80.01
USD 88,728
|
1,109
-7.4%
|
80.01
|
USD 88,728
|
|
|
2017-07-18 |
2017-07-17 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
600
-4.1%
80.10
USD 48,060
|
600
-4.1%
|
80.10
|
USD 48,060
|
|
|
2017-07-18 |
2017-07-14 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
27,914
-66.7%
80.07
USD 2,234,940
|
27,914
-66.7%
|
80.07
|
USD 2,234,940
|
|
|
2017-07-17 |
2017-07-14 |
S
Sale
|
GREGOIRE DANIEL N
General Counsel and Secretary
Officer
|
14,114
-51.2%
80.11
USD 1,130,685
|
14,114
-51.2%
|
80.11
|
USD 1,130,685
|
|
|
2017-02-27 |
2017-02-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
100
-0.9%
82.10
USD 8,210
|
100
-0.9%
|
82.10
|
USD 8,210
|
|
|
2017-02-27 |
2017-02-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
100
-0.9%
81.05
USD 8,105
|
100
-0.9%
|
81.05
|
USD 8,105
|
|
|
2017-02-27 |
2017-02-24 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
100
-0.9%
80.00
USD 8,000
|
100
-0.9%
|
80.00
|
USD 8,000
|
|
|
2017-02-27 |
2017-02-23 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
300
-2.5%
81.12
USD 24,335
|
300
-2.5%
|
81.12
|
USD 24,335
|
|
|
2017-02-27 |
2017-02-23 |
S
Sale
|
WEST JEFFREY N
SVP & Controller
Officer
|
12,912
-51.9%
80.28
USD 1,036,516
|
12,912
-51.9%
|
80.28
|
USD 1,036,516
|
|
